Education
About Us
Working with TipRanks
Follow Us
NextCell Pharma AB (SE:NXTCL)
:NXTCL
Protrans®
Influenza A, Respiratory Syncytial Virus (Rsv), Covid-19 Acute Respiratory Distress Syndrome, Metapneumovirus Pneumonia
Phase I
Active Not Recruiting
Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans®
May 18, 2021
―
Control, Protrans
Type1diabetes
Phase I/II
Completed
Wharton´s Jelly Derived Mesenchymal Stromal Cell Repeated Treatment of Adult Patients Diagnosed with Type I Diabetes
May 16, 2019
―
Protrans: Allogeneic Transplantation With Wjmscs
Type1 Diabetes Mellitus
Phase I/II
Completed
Wharton´s Jelly Derived Mesenchymal Stromal Cell Treatment of Adult Patients Diagnosed With Type I Diabetes
Nov 27, 2017
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does NextCell Pharma AB (NXTCL) have in its pipeline
NXTCL is currently developing the following drugs: Protrans®, Control, Protrans, Protrans: Allogeneic Transplantation With Wjmscs. These drug candidates are in various stages of clinical development as the company works toward FDA approval.